Ketevan Weißflog
Senior Director, Business Development EMEA
RWS
Ketevan Weissflog, LL.M., is Senior Director, Business Development – EMEA at RWS Group, where she advises global organizations and IP law firms on cross-border portfolio transitions, strategic IP management, and complex intellectual property operations.
With more than 15 years in intellectual property, she has supported corporations and IP law firms in navigating multi-jurisdictional ownership changes, post-M&A IP integrations, and global portfolio transitions across patents, trademarks, renewals, validations, and IP recordals.
As a qualified IP lawyer, Ketevan has held several senior leadership roles in international intellectual property operations and portfolio management.
Sandra Faeh
Chief Medical Officer
NVA General Practice
Derick Whitley
Founder and CEO
TRAVV
Jesse Montgomery
Head of US Healthcare Customer Success & Value Engineering
Shift Technology
Leading Healthcare Customer Success and Value Engineering, my mission has been focused on transforming customer engagement through a fusion of industry knowledge, data science, and personalized service strategies. Leverage my strategic partnerships to advance collaborative successes, resulting in the development of creative and innovative healthcare solutions and capability expansion for Shift Technology focused on payment integrity, ultimately enhancing our customer commitments and financial targets.
Zoe Kimberley
Area Counsel, Europe
AbbVie
Zoe is a Life Sciences law specialist with over 20 years’ experience in private practice and industry. She is the Area Counsel for Europe. Before this Zoe was the Legal Director for AbbVie UK & Ireland and then led the AbbVie legal team in Europe South and Central Eastern Europe. Zoe is a litigator by background and has specialized in product liability and representative/class actions since qualification in London with DAC Beachcroft.
Zoe joined AbbVie (then Abbott) in 2011 after 5 years at Clayton Utz in Sydney. Here she specialized in product liability litigation, class actions and pharma regulatory law. In Australia, Zoe worked on numerous high-profile matters including the VIOXX litigation for Merck/MSD.
Zoe holds an LLB from University College London. She is admitted to practice in England & Wales and New South Wales, Australia.
Sophie Pelé
Partner
Dechert
Sophie Pelé, a partner in Dechert's Paris office, advises in life sciences regulatory matters. She also covers foreign investment control in international transactions and strategic public law litigation.
Ranked among the leading partners in Pharma/Life Sciences: Regulatory by Chambers France 2026, recognized as a “Next Generation Partner” in France by The Legal 500 EMEA 2026 in Healthcare & Life Sciences, as well as among the best lawyers in Life Sciences by Who’s Who Legal 2025, Sophie Pelé has substantial experience in clinical trial, development, manufacturing and promotion agreements, licensing and distribution schemes, market access transparency, lifecycle management, and hospital-related public procurement.